Skip to main content
. Author manuscript; available in PMC: 2013 Oct 25.
Published in final edited form as: Aliment Pharmacol Ther. 2011 May 23;34(2):10.1111/j.1365-2036.2011.04697.x. doi: 10.1111/j.1365-2036.2011.04697.x

Table 4.

Adverse events developing within 2 weeks after TACE

Event N (%)
Post-TACE syndrome 11 (23.4)
New ascites 2 (4.3)
Ascites with hydrothorax 1 (2.1)
Active haemorrhage into tumour 1 (2.1)
Cholecystitis 1 (2.1)
Hiccups 1 (2.1)